Valuation: Teva Pharmaceutical Industries Limited

Market Cap 42.89B 0 36.73B 34.27B 31.44B 59.08B 4,104B 60.25B 407B 158B 2,057B 161B 158B 6,810B P/E 2026 *
49.4x
P/E 2027 * 20.2x
Enterprise Value 54.77B 0 46.9B 43.75B 40.15B 75.44B 5,241B 76.93B 519B 202B 2,627B 206B 201B 8,695B EV / Sales 2026 *
3.3x
EV / Sales 2027 * 2.98x
Free-Float
88.59%
Yield 2026 *
-
Yield 2027 * -
1 day-0.72%
1 week+2.99%
Current month+1.38%
1 month+14.58%
3 months+8.57%
6 months+4.85%
Current year+9.22%
1 week 10,650
Extreme 10650
11,240
1 month 9,396
Extreme 9396
11,240
Current year 8,860
Extreme 8860
11,350
1 year 5,990
Extreme 5990
11,350
3 years 3,250
Extreme 3250
11,350
5 years 2,383
Extreme 2383
11,350
10 years 2,175
Extreme 2175
20,310
Manager TitleAgeSince
Chief Executive Officer 57 01/01/2023
Director of Finance/CFO 53 22/12/2019
Chief Operating Officer 52 03/06/2024
Director TitleAgeSince
Director/Board Member 69 01/01/2009
Chairman 78 06/02/2017
Director/Board Member 65 01/09/2015
Change 5-day change 1-year change 3-year change Capi.($)
-0.72%+2.99% - - 42.89B
-2.81%+2.93%+76.40%+127.73% 1,109B
-2.21%+2.02%+49.50%+55.01% 644B
-1.56%+4.39%+25.19%+74.39% 463B
-1.25%+3.38%+39.85%+44.36% 371B
-1.11%+2.14%+21.58%+38.96% 301B
-0.55%+4.96%-0.17%+12.69% 256B
-1.95%+3.80%+46.31%+65.66% 234B
-0.07%+0.32%-16.98%-53.12% 205B
-2.82%+3.84%+20.81%+89.04% 178B
Average -0.91%+3.00%+29.17%+50.52% 417.9B
Weighted average by Cap. -0.77%+3.26%+42.71%+70.01%

Financials

2026 *2027 *
Net sales 16.58B 0 14.2B 13.25B 12.15B 22.84B 1,587B 23.29B 157B 61.26B 795B 62.26B 60.91B 2,633B 17.3B 0 14.82B 13.82B 12.68B 23.83B 1,656B 24.3B 164B 63.93B 830B 64.97B 63.56B 2,747B
Net income 1.14B 0 976M 911M 836M 1.57B 109B 1.6B 10.81B 4.21B 54.69B 4.28B 4.19B 181B 2.34B 0 2B 1.87B 1.71B 3.22B 224B 3.28B 22.15B 8.63B 112B 8.77B 8.58B 371B
Net Debt 11.88B 0 10.17B 9.49B 8.71B 16.36B 1,136B 16.68B 113B 43.88B 570B 44.6B 43.63B 1,886B 8.61B 0 7.37B 6.88B 6.31B 11.86B 824B 12.09B 81.6B 31.81B 413B 32.33B 31.63B 1,367B
Logo Teva Pharmaceutical Industries Limited
Teva Pharmaceutical Industries Ltd is a Israeli-based pharmaceutical company. The Company operates through three segments: North America, Europe and International Markets. Each business segment manages entire product portfolio in its region, including generics, specialty and over-the-counter (OTC) products. In addition to these three segments, The Company has other activities, primarily the sale of active pharmaceutical ingredients (API) to third parties, certain contract manufacturing services and an out-licensing platform offering a portfolio of products to other pharmaceutical companies through its affiliate Medis.
Employees
32,008
Date Price Change Volume
21/08/26 ILA 11,020.00 -0.72% 285,212
20/08/26 ILA 11,100.00 -0.98% 625,182
19/08/26 ILA 11,210.00 +1.17% 937,718
18/08/26 ILA 11,080.00 +2.50% 750,535
17/08/26 ILA 10,810.00 +1.03% 620,299
Trader
Investor
Global
Quality
ESG MSCI
A
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
12
Last Close Price
36.81USD
Average target price
41.40USD
Spread / Average Target
+12.47%

Quarterly revenue - Rate of surprise